Data mining analyses for precision medicine in acromegaly: a proof of concept

Predicting which acromegaly patients could benefit from somatostatin receptor ligands (SRL) is a must for personalized medicine. Although many biomarkers linked to SRL response have been identified, there is no consensus criterion on how to assign this pharmacologic treatment according to biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Gil, Joan, Marques-Pamies, Montserrat, Sampedro, Miguel, Webb, Susan M., Serra, Guillermo, Salinas, Isabel, Blanco, Alberto, Valassi, Elena, Carrato, Cristina, Picó, Antonio, García-Martínez, Araceli, Martel-Duguech, Luciana, Sardon, Teresa, Simó-Servat, Andreu, Biagetti, Betina, Villabona, Carles, Cámara, Rosa, Fajardo-Montañana, Carmen, Álvarez-Escolá, Cristina, Lamas, Cristina, Alvarez, Clara V., Bernabéu, Ignacio, Marazuela, Mónica, Jordà, Mireia, Puig-Domingo, Manel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148300/
https://www.ncbi.nlm.nih.gov/pubmed/35643771
http://dx.doi.org/10.1038/s41598-022-12955-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148300/
https://www.ncbi.nlm.nih.gov/pubmed/35643771
http://dx.doi.org/10.1038/s41598-022-12955-2

Ejemplares similares